514 filings
Page 11 of 26
8-K
iuapwymgi74qe
11 Mar 13
Departure of Directors or Certain Officers
12:00am
8-K
4uccqvozu333pwou5a
31 Jan 13
Other Events
12:00am
8-K
j46dplqvplwqj
11 Jan 13
Other Events
12:00am
8-K
q8ec02w7nbg7
8 Nov 12
Departure of Directors or Certain Officers
12:00am
8-K
c13fyac1 7uhco2y8in2
1 Nov 12
Arqule Announces Third Quarter Fiscal 2012 Results
12:00am
8-K
q1n2p1
30 Oct 12
Other Events
12:00am
8-K
clo4br4
16 Oct 12
Other Events
12:00am
8-K
ccyrehqo1 rzuiv0t
2 Oct 12
Arqule and Daiichi Sankyo Announce Discontinuation of Phase 3
12:00am
8-K
cc4tmrl9
29 Aug 12
Other Events
12:00am
8-K
yjhw pr7ypry218vw6a0
2 Aug 12
Arqule Reports Second Quarter 2012 Financial Results
12:00am
8-K
xurj2 ws5b
4 Jun 12
Positive Phase 2 Study Results for Tivantinib In Previously
12:00am
8-K
gt2hc
29 May 12
Report of Matters Voted Upon by Stockholders
12:00am
8-K
3qtwnk2h2p
18 May 12
Arqule and Daiichi Sankyo Announce Completion of Patient
12:00am
8-K
zucdh9d
17 May 12
Regulation FD Disclosure
12:00am
8-K
62fqd9ajuz3
3 May 12
Arqule Reports First Quarter 2012 Financial Results
12:00am
424B5
295px345srzu
12 Apr 12
Prospectus supplement for primary offering
12:00am